Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA 2015;313:1841–1852. https://doi.org/10.1001/jama.2015.2996.

Article  PubMed  Google Scholar 

Savarino E, Bhatia S. Achalasia. 2022;8:28. https://doi.org/10.1038/s41572-022-00356-8.

Article  Google Scholar 

Sato H et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J Gastroenterol 2019;54:621–627. https://doi.org/10.1007/s00535-018-01544-8.

Article  PubMed  Google Scholar 

van Hoeij, F.B., et al., Incidence and costs of achalasia in The Netherlands. Neurogastroenterol Motil, 2018. 30.https://doi.org/10.1111/nmo.13195.

Harvey, P.R., et al., Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. 2019. 68: p. 790–795.https://doi.org/10.1136/gutjnl-2018-316089.

Sadowski DC et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010;22:e256–e261. https://doi.org/10.1111/j.1365-2982.2010.01511.x.

Article  PubMed  CAS  Google Scholar 

Pressman A, Behar J. Etiology and Pathogenesis of Idiopathic Achalasia. J Clin Gastroenterol 2017;51:195–202. https://doi.org/10.1097/MCG.0000000000000780.

Article  PubMed  Google Scholar 

Booy JD et al. The prevalence of autoimmune disease in patients with esophageal achalasia. Dis Esophagus 2012;25:209–213. https://doi.org/10.1111/j.1442-2050.2011.01249.x.

Article  PubMed  CAS  Google Scholar 

King D et al. Achalasia Is Associated With Atopy in Patients Younger Than 40 Years of Age. Am J Gastroenterol 2021;116:416–419. https://doi.org/10.14309/ajg.0000000000001006.

Article  PubMed  Google Scholar 

Romero-Hernández, F. and J. Furuzawa-Carballeda, Autoimmune comorbidity in achalasia patients. 2018. 33: p. 203-208.https://doi.org/10.1111/jgh.13839

Sara, C., et al., Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases. Dis Esophagus, 2021. 34.https://doi.org/10.1093/dote/doaa072.

Becker J et al. Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia. Eur J Gastroenterol Hepatol 2016;28:689–695. https://doi.org/10.1097/meg.0000000000000602.

Article  PubMed  Google Scholar 

Becker J et al. The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans. Eur J Hum Genet 2016;24:1228–1231. https://doi.org/10.1038/ejhg.2015.262.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Furuzawa-Carballeda, J., et al., An original Eurasian haplotype, HLA-DRB1*14:54-DQB1*05:03, influences the susceptibility to idiopathic achalasia. 2018. 13(8): e0201676.https://doi.org/10.1371/journal.pone.0201676.

Nöthen, M.M., et al., United European Gastroenterol J. https://doi.org/10.1177/2050640618804717.

Yang L et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009;137:588–597. https://doi.org/10.1053/j.gastro.2009.04.046.

Article  PubMed  Google Scholar 

Dong F et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes 2020;12:1–24. https://doi.org/10.1080/19490976.2020.1788899.

Article  PubMed  CAS  Google Scholar 

Macfarlane S et al. Microbial colonization of the upper gastrointestinal tract in patients with Barrett’s esophagus. Clin Infect Dis 2007;45:29–38. https://doi.org/10.1086/518578.

Article  PubMed  Google Scholar 

Power, D.J., V. Ho, and J. Zhou, Association between Oral Microbiome and Gastroesophageal Reflux Severity. J Clin Med, 2024. 13.https://doi.org/10.3390/jcm13154479.

Ding N et al. Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production. Microbiol Spectr 2023;11:e0275922. https://doi.org/10.1128/spectrum.02759-22.

Article  PubMed  CAS  Google Scholar 

Yadlapati, R., P.J. Kahrilas, and M.R. Fox, Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(©). 2021. 33: p. e14058.https://doi.org/10.1111/nmo.14058.

Segata N et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60. https://doi.org/10.1186/gb-2011-12-6-r60.

Article  PubMed  PubMed Central  Google Scholar 

Sunagawa S et al. Ocean plankton. Structure and function of the global ocean microbiome. Science 2015;348:1261359. https://doi.org/10.1126/science.1261359.

Article  PubMed  CAS  Google Scholar 

Douglas, G.M. and V.J. Maffei, PICRUSt2 for prediction of metagenome functions. 2020. 38: p. 685–688.https://doi.org/10.1038/s41587-020-0548-6.

Jiang SS, Chen YX, Fang JY. Fusobacterium nucleatum: ecology, pathogenesis and clinical implications. Nat Rev Microbiol. 2025. https://doi.org/10.1038/s41579-025-01237-z.

Article  PubMed  Google Scholar 

Zhang T et al. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion. Cancer Res 2025;85:1819–1841. https://doi.org/10.1158/0008-5472.CAN-24-2580.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tahara T et al. Fusobacterium Detected in Barrett’s Esophagus and Esophageal Adenocarcinoma Tissues. Cancer Invest 2024;42:469–477. https://doi.org/10.1080/07357907.2024.2359980.

Article  PubMed  CAS  Google Scholar 

Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol 2019;17:156–166. https://doi.org/10.1038/s41579-018-0129-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carbonne C et al. Ligilactobacillus salivarius CNCM I-4866, a potential probiotic candidate, shows anti-inflammatory properties in vitro and in vivo. Front Microbiol 2023;14:1270974. https://doi.org/10.3389/fmicb.2023.1270974.

Article  PubMed  PubMed Central  Google Scholar 

Yan S et al. Ligilactobacillus salivarius CCFM 1266 modulates gut microbiota and GPR109a-mediated immune suppression to attenuate immune checkpoint blockade-induced colitis. Food Funct 2023;14:10549–10563. https://doi.org/10.1039/d3fo03867j.

Article  PubMed  CAS  Google Scholar 

Rodrigues VF et al. Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Front Immunol 2022;13:934695. https://doi.org/10.3389/fimmu.2022.934695.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zaidi AH et al. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma. BMC Cancer 2016;16:52. https://doi.org/10.1186/s12885-016-2093-8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang WS et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014;156:317–331. https://doi.org/10.1016/j.cell.2013.12.010.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pellegrini C et al. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 2018;136:345–361. https://doi.org/10.1007/s00401-018-1856-5.

Article  PubMed  CAS  Google Scholar 

Yeh, C.C., et al., Characteristics of the esophageal microbiome in patients with achalasia and its changes before and after peroral endoscopic myotomy: A pilot study. 2023. 38: p. 1307-1315.https://doi.org/10.1111/jgh.16192.

Pajecki D et al. Megaesophagus microbiota: a qualitative and quantitative analysis. J Gastrointest Surg 2002;6:723–729. https://doi.org/10.1016/s1091-255x(02)00028-8.

Article  PubMed  Google Scholar 

Park CH, Lee SK. Exploring Esophageal Microbiomes in Esophageal Diseases: A Systematic Review. J Neurogastroenterol Motil 2020;26:171–179. https://doi.org/10.5056/jnm19240.

Article  PubMed  PubMed Central  CAS